Comparison Of 3 Simultaneous Vision Iols
Published 2026 - 44th Congress of the ESCRS
Reference: PP24.017 | Type: Free paper | DOI: 10.82333/ares-nm79
Authors: Dr Deli Krizova* 1 , Katerina Tyx 1 , Dr Petra Naprstkova 1
1Lensi Eye Clinic,Prague,Czech Republic
Purpose
Setting
Lensi Eye clinic, private ophthalmology center, Prague, Czech Republic
Methods
Results
The Vivity group included 74 patients (148 eyes) the Galaxy group 67 patients (134 eyes) and the Trifocal group 22 patients (44 eyes). The mean UCDVA was 1.21 (±0.25) in the Vivity group, 1.20 (±0.2) in the Galaxy group and 1.12 (±0.3) in the Trifocal group. The mean UCIVA was 0.57 (±0.1) in the Vivity group, 0.7 (±0.05) in the Galaxy group and 0.65 (±0.2) in the Trifocal group. The mean UCNVA was 0.7 (±0.17) in the Vivity group, 0.9 (±0.07) in the Galaxy group and 0.93 (±0.25) in the Trifocal group. Overall satisfaction was comparable in all groups – 8.5 (±1.72), 8.7 (±1.9) and 8.2 (±2.2). Perception of optical side effects was higher in the Galaxy group, 2.13 (±1.41) and the Trifocal group 2.41 (±1.9) vs. 1.64 (±0.96) in the Vivity group.
Conclusions
Implantation of all three lenses shows a high level of patient satisfaction. Distance and intermediate vision were comparable with all groups. The Galaxy and the Trifocal lenses demonstrated statistically significantly better near performance with almost no need for spectacle correction. The perception of optical side effects was statistically significantly higher with the Galaxy and the Trifocal group. Although in the Galaxy group it remained at the level of only mild difficulties when directly assessed in the VFQ questionnaire.